Smartlab Europe

Press Releases

Novo Nordisk records for regulatory approval of long-acting factor VIII (N8-GP) in the US and the EU for treatment of haemophilia A

Novo Nordisk announced the submission of a Biologics License Applications (BLA) to the US FDA and a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for N8-GP, an extended half-life factor VIII for treatment of people with...

Biogen, AbbVie draw Multiple Sclerosis Drug On Inflammation Reports

RBC analyst Brian Abrahams said the decision will have "zero material impact" on Biogen as Zinbryta was expected to bring in about $400 million in 2027 revenue for the company, or less than 3% of total sales. ...

Pfizer gets optimistic response from CHMP for its CHEMOTHERAPY and MYELOGENOUS LEUKEMIA

Pfizer Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the EMA has adopted positive opinions recommending that two Pfizer hematology medicines be granted marketing authorizations in the European Union (EU). MYLOTARG™...

Elsevier collaborates with Beijing University of Chinese Medicine to enable deeper research into traditional Chinese medicine

As global interest in traditional and alternative medicine grows, Elsevier, the global information analytics business specializing in science and health, announced that it is working with Beijing University of Chinese Medicine (BUCM) to create a new taxonomy for traditional...

Enhanced ICP-MS Triple Quadrupole Technology for Ultra-trace Analysis

Semiconductor wafer fabrication plants and ultra-high purity chemical suppliers can now strengthen their monitoring of trace elements within challenging sample matrices with a new triple quadrupole inductively coupled plasma mass spectrometer (ICP-MS), offering sub-parts-per-trillion detection—making it an ideal solution...

Saneca Pharma renews Pharmascience agreement following successful quality audit

Contract development and manufacturing organisation (CDMO) Saneca Pharma has renewed an agreement with Pharmascience Inc, one of Canada’s largest pharmaceutical companies, for the manufacture and supply of prescription medicines in tablet form. The agreement, which follows...

CRF Health Scoops 2018 TrialConsent® Hat Trick as CARE Award Finalist

CRF Health, the leading provider of patient-centered eSource for the life sciences industry, announced that its TrialConsent® electronic informed consent solution has been shortlisted for the ‘Best Patient-Focused Technological Development’ category in the 2018 Clinical & Research Excellence (CARE)...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »